Trial
NCT02834975
Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
Merck Sharp & Dohme LLC
Condition
Fallopian Tube Cancer
Intervention
Pembrolizumab
Why stopped
Investigator left institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-07